Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -130,149 | 275,188 | -78,955 | -127,393 | -125,551 |
| Depreciation Amortization | -4,355 | -5,980 | -1,257 | 2,820 | 4,605 |
| Accounts receivable | 164,879 | -155,000 | -9,990 | 1,556 | 860 |
| Accounts payable and accrued liabilities | 3,723 | 839 | -2,934 | 1,215 | -3,223 |
| Other Working Capital | 146,209 | -122,610 | -19,511 | -7,766 | -3,314 |
| Other Operating Activity | -122,636 | 191,715 | 42,411 | 21,431 | 18,758 |
| Operating Cash Flow | $57,671 | $184,152 | $-70,236 | $-108,137 | $-107,865 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,590 | -1,355 | -609 | -795 | -1,101 |
| Purchase Of Investment | -546,585 | -621,702 | -191,045 | -214,874 | -286,589 |
| Sale Of Investment | 498,843 | 323,574 | 152,396 | 307,137 | 271,830 |
| Investing Cash Flow | $-49,332 | $-299,483 | $-39,258 | $91,468 | $-15,860 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 23,343 | 26,453 | 171,246 | 19,001 | 130,112 |
| Other Financing Activity | -479 | -600 | -769 | -163 | -189 |
| Financing Cash Flow | $22,864 | $25,853 | $170,477 | $18,838 | $129,923 |
| Exchange Rate Effect | N/A | N/A | N/A | -90 | -126 |
| Beginning Cash Position | 97,474 | 186,952 | 125,969 | 123,890 | 117,818 |
| End Cash Position | 128,677 | 97,474 | 186,952 | 125,969 | 123,890 |
| Net Cash Flow | $31,203 | $-89,478 | $60,983 | $2,079 | $6,072 |
| Free Cash Flow | |||||
| Operating Cash Flow | 57,671 | 184,152 | -70,236 | -108,137 | -107,865 |
| Capital Expenditure | -1,590 | -1,355 | -609 | -795 | -1,101 |
| Free Cash Flow | 56,081 | 182,797 | -70,845 | -108,932 | -108,966 |